Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells

Journal of Experimental Medicine

Volumn 192, Issue 9, 2000, Pages 1249-1260

  Sevilla, Noemí ^a   Kunz, Stefan ^a   Holz, Andreas ^a   Lewicki, Hanna ^a   Homann, Dirk ^a   Yamada, Hiroki ^b   Campbell, Kevin P ^b   De La Torre, Juan C ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

CD11c+ DEC 205+ cells; Lymphocytic choriomeningitis virus; Selection; Tropism; Viral receptor

Indexed keywords

CD11 ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE DEFICIENCY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SPLEEN; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11; CELL LINE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CRICETINAE; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; DYSTROGLYCANS; IMMUNOSUPPRESSION; IN SITU HYBRIDIZATION; LECTINS, C-TYPE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0034613731     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.9.1249     Document Type: Article

References (57)

1. Anatomy of viral persistence: Mechanisms of persistence and associated disease
2. Viruses can cause disease in the absence of morphological evidence of cell injury: Implication for uncovering new diseases in the future
3. Persistance of viruses
4. Virus-induced immunosuppression: Infections with measles virus and human immunodeficiency virus
5. Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections
6. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection
7. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immunosuppression
8. Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect
9. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: Role in suppression of cytotoxic T lymphocyte response and viral persistence
10. Organ specific selection of viral variants during chronic infection
11. Virus-induced immunosuppression: Kinetic analysis of the selection of a mutation associated with viral persistence
12. Competitive selection in vivo by a cell for one variant over another: Implications for RNA virus quasispecies in vivo
13. Molecular determinants of macrophage tropism and viral persistence: Importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus
14. Tissue-mediated selection of viral variants: Correlation between glycoprotein mutation and growth in neuronal cells
15. Genetic basis of viral persistence: Single amino acid change in the viral polymerase affects ability of lymphocytic choriomeningitis virus to persist in adult mice
16. -)
17. Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence
18. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
19. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
20. Dystroglycan versatility
21. Dystroglycan inside and out
22. Proteins of lymphocytic choriomeningitis virus: Antigenic topography of the viral glycoproteins
23. Characterization of lymphocytic choriomeningitis virus-binding protein(s): A candidate cellular receptor for the virus
24. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains
25. Variants able to cause growth hormone deficiency syndrome are present within the disease-nil WE strain of lymphocytic choriomeningitis virus
26. Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections
27. Protein structure of lymphocytic choriomeningitis virus: Evidence for a cell-associated precursor of the virion glycopeptides
28. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
29. + cells but markedly decreased helper cell activity in mice lacking CD4
30. Viruslymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset
31. In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection
32. F4/80, a monoclonal antibody directed specifically against the mouse macrophage
33. Molecular and developmental characterization of novel cDNAs of the myelin-associated/oligodendrocytic basic protein
34. Measles virus infection in a transgenic model: Virus-induced immunosuppression and central nervous system disease
35. Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV)
36. Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus
37. Virus-triggered acquired immuno-deficiency by cytotoxic T-cell-dependent destruction of anti gen-presenting cells and lymph follicle structure
38. The distinct leucocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
39. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
40. A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome
41. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alphadystroglycan with laminin
42. Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification
43. RNA viral population as quasispecies
44. RNA virus mutations and fitness for survival
45. Source for influenza pandemics
46. Population structure of pathogens: The role of immune selection
47. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during pri mary infection demonstrated by rapid selection of CTL escape virus
48. Dendritic cells and the control of immunity
49. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells
50. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses
51. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes
52. Dendritic cells in the T-cell areas of lymphoid organs
53. Pathogenic aspects of measles virus infections
54. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells
55. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry
56. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology
57. Mature dendritic cells infected with herpes simplex virus 1 exhibited inhibited T-cell stimulatory capacity